ACADIAN ASSET MANAGEMENT LLC - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 9 filers reported holding ARCA BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q4 2021$123,000
-10.9%
57,822
+176.6%
0.00%
-100.0%
Q2 2020$138,000
+72.5%
20,908
-26.4%
0.00%
Q1 2020$80,000
-19.2%
28,423
+64.0%
0.00%
Q4 2019$99,000
+6.5%
17,3330.0%0.00%
Q3 2019$93,000
-27.3%
17,3330.0%0.00%
-100.0%
Q2 2019$128,00017,3330.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Western Standard LLC 1,174,270$2,360,2832.13%
BML Capital Management, LLC 706,930$1,420,9291.30%
Newtyn Management, LLC 300,000$603,0000.15%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$94,3650.00%
OSAIC HOLDINGS, INC. 55$1100.00%
DIMENSIONAL FUND ADVISORS LP 42,514$85,4530.00%
Parallel Advisors, LLC 244$4900.00%
BANK OF AMERICA CORP /DE/ 31$620.00%
WELLS FARGO & COMPANY/MN 75$1510.00%
NORTHERN TRUST CORP 20,982$42,1740.00%
View complete list of ARCA BIOPHARMA INC shareholders